1. Repository of OAI
Ελληνικά   English  

Browsing by Author Elisaf, M. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 249 to 268 of 573 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Fenofibrate and losartanDaskalopoulou, S. S.; Mikhailidis, D. P.; Athyros, V. G.; Papageorgiou, A. A.; Elisaf, M. S.24-Nov-2015-
Fenofibrate in primary biliary cirrhosis: a pilot studyLiberopoulos, E. N.; Florentin, M.; Elisaf, M. S.; Mikhailidis, D. P.; Tsianos, E.24-Nov-2015-
Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemiaFilippatos, T. D.; Elisaf, M. S.24-Nov-2015-
Fenofibrate: metabolic and pleiotropic effectsTsimihodimos, V.; Miltiadous, G.; Daskalopoulou, S. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Fever with rash following zolendronic acid administrationRizos, E. C.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015-
Fibrate treatment can increase serum creatinine levelsTsimihodimos, V.; Kakafika, A.; Elisaf, M. S.24-Nov-2015-
Fibrate-associated adverse effects beyond muscle and liver toxicityFlorentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Fibrate-induced increase in serum urea and creatinine levelsTsimihodimos, V.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Fibrates and C-reactive proteinKostoula, A.; Elisaf, M. S.24-Nov-2015-
Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemiaElisaf, M. S.; Panteli, K.; Theodorou, J.; Siamopoulos, K. C.24-Nov-2015-
Fractional excretion of potassium in normal subjects and in patients with hypokalaemiaElisaf, M. S.; Siamopoulos, K. C.24-Nov-2015-
Galectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritisPanoulas, V. F.; Douglas, K. M.; Smith, J. P.; Metsios, G. S.; Elisaf, M. S.; Nightingale, P.; Kitas, G. D.24-Nov-2015-
Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomicsPsihogios, N. G.; Gazi, I. F.; Elisaf, M. S.; Seferiadis, K. I.; Bairaktari, E. T.24-Nov-2015-
Genetic and environmental factors affecting the response to statin therapy in patients with familial hypercholesterolemiaMiltiadous, G.; Xenophontos, S.; Bairaktari, E.; Tsimixodimos, V.; Kalogirou, M.; Cariolou, M.; Elisaf, M. S.24-Nov-2015-
Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemiaMiltiadous, G.; Xenophontos, S.; Bairaktari, E.; Ganotakis, M.; Cariolou, M.; Elisaf, M. S.24-Nov-2015-
Genetic polymorphisms affecting the phenotypic expression of patients with molecularly defined familial hypercholesterolaemiaMiltiadous, G.; Cariolou, M.; Elisaf, M. S.24-Nov-2015-
Genetic polymorphisms of the apolipoprotein A-IV in a Greek population and their relation to plasma lipid and lipoprotein levelsMiltiadous, G.; Hatzivassiliou, M.; Bashiardes, E.; Bairaktari, E.; Cariolou, M. A.; Elisaf, M. S.24-Nov-2015-
Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levelsSkrapari, I.; Perrea, D.; Ioannidis, I.; Karabina, S. A.; Elisaf, M. S.; Tselepis, A. D.; Karagiannacos, P.; Katsilambros, N.24-Nov-2015-
HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemiaMiltiadous, G.; Cariolou, M. A.; Elisaf, M. S.24-Nov-2015-
Hemorrhagic fever with renal syndrome in an endemic area of GreeceSiamopoulos, K. C.; Elisaf, M. S.; Antoniadis, A.; Moutsopoulos, H. M.24-Nov-2015-
Showing results 249 to 268 of 573 < previous   next >